{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:55:25Z","timestamp":1787500525763,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejphar.2023.175531","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T11:56:35Z","timestamp":1674215795000},"page":"175531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Empagliflozin ameliorates cardiac dysfunction in heart failure mice via regulating mitochondrial dynamics"],"prefix":"10.1016","volume":"942","author":[{"given":"YiTing","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunYu","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WanYing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShengChan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShiGeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanDi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiXin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiJun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175531_bib1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/eurheartj\/ehaa943","article-title":"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","volume":"42","author":"Abraham","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175531_bib2","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100067R","article-title":"Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis","volume":"35","author":"Adebayo","year":"2021","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.175531_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","article-title":"SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob(-\/-) mice","volume":"18","author":"Adingupu","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2023.175531_bib4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175531_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Arag\u00f3n-Herrera","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175531_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2023.175531_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacbts.2017.07.003","article-title":"Empagliflozin prevents worsening of cardiac function in an experimental model of pressure overload-induced heart failure","volume":"2","author":"Byrne","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejphar.2023.175531_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201801322","article-title":"Increased dynamin-related protein 1-dependent mitochondrial fission contributes to high-fat-diet-induced cardiac dysfunction and insulin resistance by elevating tafazzin in mouse hearts","volume":"63","author":"Chang","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib10","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-019-11327-1","article-title":"Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis","volume":"10","author":"Chung","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.175531_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109147","article-title":"Mdivi-1 alleviates cardiac fibrosis post myocardial infarction at infarcted border zone, possibly via inhibition of Drp1-Activated mitochondrial fission and oxidative stress","volume":"718","author":"Ding","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2023.175531_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/ars.2020.8248","article-title":"Punicalagin protects against diabetic cardiomyopathy by promoting opa1-mediated mitochondrial fusion via regulating PTP1B-Stat3 pathway","volume":"35","author":"Fu","year":"2021","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2023.175531_bib13","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1111\/jcmm.14662","article-title":"MCU Up-regulation contributes to myocardial ischemia-reperfusion Injury through calpain\/OPA-1-mediated mitochondrial fusion\/mitophagy Inhibition","volume":"23","author":"Guan","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.175531_bib14","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175531_bib15","first-page":"1071","article-title":"Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission","volume":"116","author":"Huang","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.712338","article-title":"Intestinal barrier dysfunction exacerbates neuroinflammation via the TLR4 pathway in mice with heart failure","volume":"12","author":"Huo","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jenca","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejphar.2023.175531_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7120195","article-title":"Adrenergic regulation of drp1-driven mitochondrial fission in cardiac physio-pathology","volume":"7","author":"Jhun","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2023.175531_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41401-020-00518-y","article-title":"Drp1-dependent mitochondrial fission in cardiovascular disease","volume":"42","author":"Jin","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175531_bib20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1042\/BST20160129","article-title":"Mitochondrial fission and fusion","volume":"44","author":"Lee","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2023.175531_bib21","series-title":"Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism","author":"Lee","year":"2019"},{"key":"10.1016\/j.ejphar.2023.175531_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2023.175531_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fphar.2020.00815","article-title":"Shenmai injection protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial homeostasis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175531_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018298","article-title":"Direct cardiac actions of the sodium glucose Co-transporter 2 inhibitor empagliflozin improve myocardial oxidative phosphorylation and attenuate pressure-overload heart failure","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2023.175531_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102098","article-title":"Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2\u03b1-Stat3 pathway in diabetic cardiomyopathy","volume":"46","author":"Liu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.175531_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105788","article-title":"Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice","volume":"161","author":"Liu","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2023.175531_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105449","article-title":"Lipoic acid alleviates schistosomiasis-induced liver fibrosis by upregulating Drp1 phosphorylation","volume":"206","author":"Luo","year":"2020","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejphar.2023.175531_bib28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1242\/jcs.159186","article-title":"OPA1 processing in cell death and disease - the long and short of it","volume":"129","author":"MacVicar","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2023.175531_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-016-9530-2","article-title":"Mitochondrial dynamics and cell death in heart failure","volume":"21","author":"Mar\u00edn-Garc\u00eda","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2023.175531_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107492","article-title":"The SGLT2 inhibitor empagliflozin negatively regulates IL-17\/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK\/mTOR\/autophagy pathway","volume":"94","author":"Meng","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2023.175531_bib31","article-title":"Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts","volume":"6","author":"Mizuno","year":"2018","journal-title":"Phys. Rep."},{"key":"10.1016\/j.ejphar.2023.175531_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165807","article-title":"Empagliflozin improves left ventricular diastolic function of db\/db mice","volume":"1866","author":"Moellmann","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.175531_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165807","article-title":"Empagliflozin improves left ventricular diastolic function of db\/db mice","volume":"1866","author":"Moellmann","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.175531_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.devcel.2021.02.009","article-title":"Quality control of the mitochondrion","volume":"56","author":"Ng","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2023.175531_bib35","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","article-title":"Mitochondria: in sickness and in health","volume":"148","author":"Nunnari","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175531_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163972","article-title":"Targeting mitochondrial fission using mdivi-1 in A clinically relevant large animal model of acute myocardial infarction: a pilot study","volume":"20","author":"Ong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175531_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.carpath.2015.09.009","article-title":"Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure","volume":"25","author":"Pisano","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.ejphar.2023.175531_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1096\/fj.201901671R","article-title":"Mitochondrial fusion mediated by fusion promotion and fission inhibition directs adult mouse heart function toward a different direction","volume":"34","author":"Qin","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.175531_bib39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41569-022-00703-y","article-title":"The role of mitochondrial fission in cardiovascular health and disease","volume":"19","author":"Quiles","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.664181","article-title":"Sodium-glucose CoTransporter-2 inhibitor empagliflozin ameliorates sunitinib-induced cardiac dysfunction via regulation of AMPK-mTOR signaling pathway-mediated autophagy","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175531_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ib\u00e1\u00f1ez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejphar.2023.175531_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.122.060805","article-title":"SGLT2 inhibitors in heart failure: targeted metabolomics and energetic metabolism","volume":"146","author":"Santos-Gallego","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175531_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jcmg.2020.07.042","article-title":"Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis\/stiffness in nondiabetic heart failure: a multimodality study","volume":"14","author":"Santos-Gallego","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ejphar.2023.175531_bib45","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics","volume":"73","author":"Santos-Gallego","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib46","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/ars.2021.0145","article-title":"Mitochondrial fusion, fission, and mitophagy in cardiac diseases: challenges and therapeutic opportunities","volume":"36","author":"Scheffer","year":"2022","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2023.175531_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","article-title":"Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2023.175531_bib48","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbabio.2016.04.002","article-title":"Bioenergetic roles of mitochondrial fusion","volume":"1857","author":"Silva Ramos","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2023.175531_bib49","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2017.09.023","article-title":"Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence","volume":"26","author":"Song","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2023.175531_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10456-022-09835-8","article-title":"Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance","volume":"25","author":"Sun","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejphar.2023.175531_bib51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2337\/db19-0991","article-title":"Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice","volume":"69","author":"Sun","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2023.175531_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.758080","article-title":"Sodium-glucose Co-transporter 2 inhibition with empagliflozin improves cardiac function after cardiac arrest in rats by enhancing mitochondrial energy metabolism","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175531_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cphy.c140055","article-title":"Pathophysiology of heart failure","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2020.04.015","article-title":"The role of Drp1 in mitophagy and cell death in the heart","volume":"142","author":"Tong","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib56","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011072","article-title":"Mechanisms of mitochondrial fission and fusion","volume":"5","author":"van der Bliek","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2023.175531_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad0116","article-title":"Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice","volume":"350","author":"Wai","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.175531_bib58","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/1061186X.2022.2064479","article-title":"Empagliflozin alleviates myocardial I\/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK\/ATF4\/Beclin1 pathway","volume":"30","author":"Wang","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejphar.2023.175531_bib59","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.175531_bib60","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.apsb.2020.03.004","article-title":"Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2023.175531_bib61","article-title":"Calenduloside E ameliorates myocardial ischemia-reperfusion injury through regulation of AMPK and mitochondrial OPA1","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.175531_bib62","article-title":"Protective effect of optic atrophy 1 on cardiomyocyte oxidative stress: roles of mitophagy, mitochondrial fission, and MAPK\/ERK signaling","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.175531_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41419-019-2218-5","article-title":"Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175531_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.745058","article-title":"Empagliflozin induces white adipocyte browning and modulates mitochondrial dynamics in KK cg-ay\/J mice and mouse adipocytes","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00395-022-00956-1","article-title":"Bone marrow-derived na\u00efve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin","volume":"117","author":"Xu","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175531_bib67","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1042\/CS20190585","article-title":"Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice","volume":"133","author":"Xue","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2023.175531_bib68","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2023.175531_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12542","article-title":"Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion\/mitophagy and activating the AMPK-OPA1 signaling pathways","volume":"66","author":"Zhang","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.ejphar.2023.175531_bib70","article-title":"Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside","volume":"66","author":"Zhou","year":"2021","journal-title":"#N\/A"},{"key":"10.1016\/j.ejphar.2023.175531_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.175531_bib72","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175531_bib73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-022-01532-6","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion injury through improving mitochondrial homeostasis","volume":"21","author":"Zou","year":"2022","journal-title":"Cardiovasc. Diabetol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:42:04Z","timestamp":1736329324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":73,"alternative-id":["S0014299923000420"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175531","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin ameliorates cardiac dysfunction in heart failure mice via regulating mitochondrial dynamics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175531"}}